Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award

Published on by Invention Awards

Dr. Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award 

University of Wroclaw | Poland

Dr. Bożena Futoma-Kołoch is an accomplished microbiologist whose research integrates microbial pathogenesis, antimicrobial resistance, and host–pathogen interactions, with a particular focus on Salmonella enterica. She is an Assistant Professor in the Department of Microbiology at the University of Wrocław, where she has built a coherent and internationally recognized research program grounded in molecular microbiology, immunology, and environmental microbiology. Her scientific work has substantially advanced understanding of how environmental stressors especially disinfectants, antiseptics, and human serum—shape bacterial virulence and survival. A central theme of her research is the phenomenon of cross-resistance, whereby exposure to biocides influences bacterial tolerance to antibiotics and serum-mediated immune defenses. Through detailed phenotypic and proteomic analyses, Dr. Futoma-Kołoch has demonstrated that changes in outer membrane proteins (OMPs) play a pivotal role in mediating resistance to serum complement, antibiotics, and disinfectants. These findings have provided new mechanistic insights into bacterial adaptation and have identified OMPs as promising biomarkers and potential therapeutic targets in the fight against multidrug-resistant pathogens. Her habilitation work, “Effect of disinfectants and serum on the phenotype associated with virulence in non-typhoid Salmonella enterica strains” (2024), represents a significant milestone, consolidating years of systematic research into how chemical and immunological pressures modulate virulence-associated traits. This research has strong translational relevance for public health, food safety, and infection control, particularly in the context of increasing antimicrobial resistance and widespread biocide use. Dr. Futoma-Kołoch is also actively engaged in interdisciplinary and applied research. Dr. Futoma-Kołoch’s scholarly output includes influential review articles that are widely cited and shape current thinking on bacterial virulence, serum resistance, and antimicrobial defense mechanisms. Her leadership in international collaborations, participation in COST Actions, and service as an editor and reviewer for high-impact journals further attest to her standing in the global microbiology community. Overall, her research profile reflects originality, continuity, and significant impact on both basic science and applied infectious disease research.

Citation Metrics (Google Scholar)

500
400
300
200
100
0

Citations
407

i10index
30

h-index
12

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications


Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds

– World Journal of Microbiology and Biotechnology, 2021 | Cited by: 57

 

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Hua He | Cardiovascular diseases | Best Researcher Award

Published on by Invention Awards

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University, China

Profile

Orcid

🎓 Early Academic Pursuits

Professor Hua He graduated from the prestigious Peking Union Medical College in 2006, earning a doctorate in internal medicine. This solid academic foundation laid the groundwork for his career in cardiovascular medicine and clinical research, with an early focus on coronary heart disease, arrhythmia, and heart failure.

💼 Professional Endeavors

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor He has dedicated himself to advancing clinical and basic research in cardiovascular diseases. His leadership includes managing several key projects related to ischemic heart disease and stem cell therapies, reflecting his commitment to bridging clinical practice and innovative research.

🔬 Contributions and Research Focus

Over recent years, Professor He has focused on the therapeutic potential of human umbilical cord mesenchymal stem cell exosomes in the treatment of ischemic heart disease. His pioneering work demonstrates how these exosomes improve ventricular remodeling and long-term cardiac function following myocardial infarction. He has also contributed to elucidating the molecular mechanisms and biological dynamics of stem cell-derived exosomes both in vivo and in vitro, publishing 17 articles in high-impact journals.

🌍 Impact and Influence

Through his role as senior editor of Clinical and Applied Thrombosis Hemostasis and reviewer for Stem Cell Research and Therapy, Professor He has influenced the direction of research in cardiovascular regenerative medicine. His expertise is further recognized by his involvement as a project reviewer for the National Natural Science Foundation of China and as a medical identification expert for several Beijing medical associations.

📊 Academic Citations

With 17 journal publications and a citation index of 7, Professor He’s research contributions are well acknowledged in the scientific community. His ongoing research projects (eight completed or in progress) and patent filings highlight a strong commitment to innovation and knowledge dissemination.

💻 Technical Skills

Professor He possesses advanced technical skills in stem cell biology, molecular analysis, and cardiovascular disease modeling. His proficiency in translational research techniques has enabled successful exploration of novel therapies for myocardial ischemia/reperfusion injury.

🎓 Teaching Experience

In addition to his research activities, Professor He contributes to medical education by mentoring young clinicians and researchers, fostering the next generation of cardiovascular specialists through practical and theoretical training.

🔮 Legacy and Future Contributions

Professor He’s research advances the frontier of regenerative cardiovascular medicine, particularly in stem cell-derived exosome therapy. His ongoing projects and expert collaborations promise significant breakthroughs that could transform treatment protocols for ischemic heart disease worldwide.

📚 Selected Publications

  • He, H., et al. "Human umbilical cord mesenchymal stem cell exosomes improve ventricular remodeling after myocardial infarction." Journal of Cardiovascular Research, 2021.

  • He, H., Wang, X., et al. "Therapeutic effects of mesenchymal stem cell exosomes on ischemia/reperfusion injury in rat models." Stem Cell Therapy, 2022.

  • He, H., Zhang, Y., et al. "Molecular mechanisms of exosome-mediated cardiac repair post-infarction." Cellular and Molecular Medicine, 2020.

  • He, H., Li, Q., et al. "In vivo biodistribution and pharmacodynamics of human umbilical cord MSC-derived exosomes." Frontiers in Cardiovascular Medicine, 2019.

  • He, H., Chen, J., et al. "Mesenchymal stem cell exosomes modulate inflammation and fibrosis in cardiac tissue." International Journal of Cardiology, 2021.

  • He, H., Liu, S., et al. "Safety assessment of MSC exosome therapy in myocardial ischemia/reperfusion." Stem Cells Translational Medicine, 2023.

  • He, H., et al. "Exosome-based delivery of therapeutic molecules for heart failure treatment." Theranostics, 2022.

 

Emilia Severin | Rare Diseases | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Carol Davila University of Medicine and Pharmacy, Romania

Profile

Orcid

📚 Early Academic Pursuits

Professor Emilia Severin embarked on her academic journey at the University of Bucharest, earning a degree in Biology (1973–1977), followed by a Master’s degree in Ecology (1977–1978). Her passion for biological sciences led her to pursue a Ph.D. in Biology (1990–1994) at the same institution. She continued her academic enrichment with specialized training in mutagenesis (micronuclei, SCE) at Università degli Studi di Padova, Italy (1994–1995), and advanced molecular techniques (PCR) at Consiglio Nazionale delle Ricerche, Milan, Italy (1997).

🧬 Professional Endeavors

Professor Severin’s professional career is deeply rooted at the prestigious "Carol Davila" University of Medicine and Pharmacy in Bucharest, Romania. She started as an Assistant Professor of Human Genetics in 1982 and steadily advanced to Associate Professor in 1995, then to Full Professor in 1999 within the Faculty of Dentistry. Since 1999, she has also served as the Head of the Genetics Discipline, showcasing her leadership and academic prowess. Additionally, she has been a mentor for the Ph.D. training program since 2002, shaping future experts in genetics.

🏆 Contributions and Research Focus

Professor Severin has a strong research focus on Genetics in Dentistry, Cytogenetics, and Rare Diseases. She has significantly contributed to the understanding of genetic components in dental and craniofacial disorders and has been actively involved in integrating genetic knowledge into clinical dentistry. Her participation in high-level European and national expert groups on rare diseases has had a tangible impact on shaping health policies and improving patient care for rare conditions.

🌍 Impact and Influence

Her influence extends beyond Romania through her role as a Member of the European Commission Expert Group on Rare Diseases (2013–2018) and her ongoing service as the Vice-president of the National Counsel for Rare Diseases. Her leadership in the Medical Genetics Commission of the Romanian Ministry of Health since 2010 illustrates her integral role in national health governance. Moreover, she helped guide the academic policies as a Member of the Academic Senate (2008–2012) and as Head of the Preclinical Sciences Department during the same period.

📖 Academic Cites and Recognition

Professor Severin’s scholarly presence is recognized through her ORCID (0000-0003-3901-615X), which reflects her scientific contributions. She has represented Romania at numerous international conferences and workshops organized by prestigious bodies such as the American College of Medical Genetics and the American Society of Human Genetics (ASHG), contributing to the global dialogue in genetics education and clinical practice.

🖥️ Technical Skills

Professor Severin is highly skilled in advanced genetic techniques including PCR, mutagenesis assays (micronuclei, SCE), cytogenetics, array technology, and next-generation sequencing. Her participation in specialized technical courses across Europe and North America has equipped her with cutting-edge laboratory and bioinformatics expertise necessary for modern genetic research and diagnostics.

👩‍🏫 Teaching Experience

An esteemed educator, Professor Severin has dedicated over four decades to teaching Human Genetics to medical and dentistry students. Her efforts to enhance undergraduate genetics education are evident through her active participation in multiple ASHG Undergraduate Genetics Education Workshops. Her ability to bridge complex genetic concepts with clinical practice has made her a cornerstone of the genetics curriculum at the Faculty of Dentistry, Carol Davila University.

🌟 Legacy and Future Contributions

Through her dynamic career, Professor Emilia Severin has profoundly shaped the field of medical and dental genetics in Romania and beyond. Her dedication to research on rare diseases and her advocacy for integrating genetics into clinical settings continue to inspire a new generation of geneticists and healthcare providers. Looking forward, her ongoing mentorship of Ph.D. candidates and active participation in genetics policy development ensures that her influence will persist and evolve, aligning with the advances of precision medicine and genomics.

 Notable Publications

Publication Title: Failure of Tooth Development: Prevalence, Genetic Causes and Clinical Features
Author(s): Emilia Severin
Journal/Publisher: IntechOpen Book Series
Year: 2021

Publication Title: History of Medical Genetics in Romania
Author(s): Emilia Severin
Journal/Publisher: Publishing House of the Romanian Academy
Year: 2020

Publication Title: Medical Genetics, Chapter 8 – Human Population Genetics; Chapter 20 – Genetic Approaches to Human Diseases Therapy
Author(s): Emilia Severin (Contributor)
Journal/Publisher: Ed. Polirom
Year: 2017

Publication Title: Human Genetics - Concepts and Practical Applications (1st and 2nd Editions)
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Medicala
Year: 1st edition – 2002; 2nd edition – 2004

Publication Title: Genetics of Dento-Maxillary Anomalies
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Scripta
Year: 1998

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Published on by Invention Awards

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Poznan University of Medical Sciences, Poland.

Professor Jolanta Dorszewska is a distinguished neuroscientist and full professor at the Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poland. With over three decades of research and academic leadership, she has made pioneering contributions to the understanding of neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases. As the head of her department since 2004, she continues to inspire innovation in molecular neurobiology, epigenetics, and neurochemistry.

Profile

Scopus
Orcid

🎓 Education

Prof. Dorszewska’s academic journey began at the Faculty of Pharmacy, Poznan University of Medical Sciences, where she earned her MSc in Pharmacy (1987) with distinction. She continued her academic growth with a PhD (1996) in medical sciences and attained postdoctoral habilitation (2004). She became a Full Professor in 2016, after rigorous training and board certifications in pharmaceutical analytics and medical genetics.

💼 Professional Experience

Her professional path is deeply rooted in neuroscience and pharmacology. She served as an assistant in the Departments of Pharmacy and Clinical Neurochemistry before becoming a Research Associate and later the Head of the Laboratory of Neurobiology. Internationally, she gained experience as a Research Scientist in New York (1999-2000). She has also taught extensively, including at the National High Medical School in Piła.

🔬 Research Interests

Prof. Dorszewska’s research covers a rich spectrum—from analyzing lipid and sterol levels in hypoxia to the genetic and molecular pathways of neurodegeneration. Her work involves advanced techniques like HPLC, ELISA, Western Blot, PCR, and focuses on biomarkers, genetic polymorphisms, miRNAs, and apoptosis in diseases such as Alzheimer’s, Parkinson’s, epilepsy, and migraine. She is especially known for studies on homocysteine metabolism and catecholamine gene mutations.

🏆 Awards & Recognition

She has earned numerous accolades and holds editorial and leadership roles in prestigious journals including Frontiers in Molecular Neuroscience, Journal of Integrative Neuroscience, and Current Alzheimer Research. As a Guest Editor for six major neuroscience journals and a member of international neurological associations, her global contributions to science are widely respected. She was also an Honorary Member of the 12th CONy World Congress (2018).

📚 Selected Publications

🧬 Genetics and Parkinson's Disease

Title: Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson's disease
Journal: IBRO Neuroscience Reports
Date: June 2025
DOI: 10.1016/j.ibneur.2025.01.016
Authors: Jolanta Dorszewska et al.
🔬 Focus: Investigates the role of ZNF746 gene variants and related proteins in the pathophysiology of Parkinson’s disease.

🧠 Neurorehabilitation and Multiple Sclerosis

Title: Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
Journal: Sclerosis
Date: April 3, 2025
DOI: 10.3390/sclerosis3020013
Authors: Katarzyna Wiszniewska et al., including Jolanta Dorszewska
🧘‍♀️ Focus: Explores physical therapy interventions and their molecular impacts in MS patients.

🦠 Parasitic Infections and Proteinopathies

Title: Unraveling the Role of Proteinopathies in Parasitic Infections
Journal: Biomedicines
Date: March 3, 2025
DOI: 10.3390/biomedicines13030610
Authors: Mikołaj Hurła et al., including Jolanta Dorszewska
🧫 Focus: Connects neurodegenerative proteinopathies with parasitic infection mechanisms.

🧪 Neuropharmacology and Aging

Title: Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
Journal: International Journal of Molecular Sciences
Date: February 14, 2025
DOI: 10.3390/ijms26041634
Authors: Małgorzata Anna Lewandowska et al., including Jolanta Dorszewska
🧠 Focus: Studies the impact of Memantine on aging-related neurochemical changes.

🧠 Brain Imaging and Migraine

Title: fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura
Journal: Neurology International
Date: January 21, 2025
DOI: 10.3390/neurolint17020015
Authors: Damian Pikor et al., including Jolanta Dorszewska
🧲 Focus: Uses fMRI to explore visual cortex abnormalities in migraine with aura.

 

 

 

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.

 

 

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Published on by Invention Awards

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Institute of Telecommunications, Portugal.

Ana Filipa Soares Pires is a Junior Researcher specializing in biomaterials and bioelectronic devices at Instituto de Telecomunicações, Instituto Superior Técnico. Her research focuses on creating systems that respond to stimuli like light, electricity, and magnetism to guide cell behavior for tissue regeneration. She is particularly interested in drug delivery systems, such as liposomes, nanoparticles, and hydrogels, and has made groundbreaking contributions to bioelectronics and personalized medicine. Ana's work on biodegradable LEDs for real-time monitoring of anticancer drugs has propelled innovations in precision medicine and tissue engineering.

Profile

Scopus

Orcid

Education 🎓

Ana Filipa Soares Pires holds a Ph.D. in Radiation Biology and Biophysics, where she specialized in biomaterials and bioelectronics. Her educational background also includes Master's Fellowships in Pharmacokinetic Analysis (PEstOE/EEI/LA0008/2014), focusing on the pharmacokinetics of nanostructured films, and in Textile Electrode Design (2014), where she innovated designs using cotton and silk electrodes to collect electrical signals from living tissue. Her education laid the foundation for her pioneering work in bioelectronics, tissue engineering, and drug delivery systems.

Experience  💼

Ana's research experience spans multiple interdisciplinary projects, including the development of drug delivery systems, tissue scaffolds, and biosensors. She has collaborated with leading researchers from institutions such as IFSCAR (Brazil) and Synchrotron Facilities (Denmark), and her work is published in prestigious journals like European Polymer Journal and Fungal Biology. As a guest editor, Ana has also contributed to the scientific community by editing special issues and reviewing for top-tier journals.

Research Interests 🔬

Biomaterials & Bioelectronics: Developing biodegradable LEDs for real-time monitoring of anticancer drugs.

Drug Delivery Systems: Improving the precision and safety of therapeutic treatments using liposomes, nanoparticles, and hydrogels.

Tissue Engineering: Engineering conducting scaffolds for neural tissue regeneration.

Molecular Interactions: Exploring the interaction between catechins and cellular membranes for their antioxidant effects.

Awards and Honors 🏆

Ana has been recognized for her exceptional contributions to bioelectronics and biomaterials. Some notable projects she has worked on include:

European Innovation Council, EIC PathFinder (2022-2025)

Co-PI for "Magnetic field-assisted MSCs-based therapies" (La Caixa Foundation, 2022)

Master Fellow in Pharmacokinetic Analysis of Nanostructured Films

Selected Publications 📚

Heparinized Acellular Hydrogels for Magnetically Induced Wound Healing Applications

Authors: Pires, F., Silva, J.C., Ferreira, F.C., Portugal, C.A.M.
Journal: ACS Applied Materials and Interfaces
Year: 2024, Volume: 16(8), Pages: 9908–9924
Citations: 4

Indium-gallium-zinc-oxide Based Semitransparent Electrodes on Flexible Substrates for Biodegradable Electronics

Authors: Pompilio, M., Gharehbagh, J.S., Krik, S., Ciocca, M., Cacialli, F.
Conference: 6th IEEE International Flexible Electronics Technology Conference, IFETC 2024 - Proceedings
Year: 2024

Magnetic-Responsive Liposomal Hydrogel Membranes for Controlled Release of Small Bioactive Molecules—An Insight into the Release Kinetics

Authors: Pereira, L., Ferreira, F.C., Pires, F., Portugal, C.A.M.
Journal: Membranes
Year: 2023, Volume: 13(7), Article: 674
Citations: 5

The Impact of Blue Light in Monolayers Representing Tumorigenic and Nontumorigenic Cell Membranes Containing Epigallocatechin-3-gallate

Authors: Pires, F., Magalhães-Mota, G., Geraldo, V.P.N., Oliveira, O.N., Raposo, M.
Journal: Colloids and Surfaces B: Biointerfaces
Year: 2020, Volume: 193, Article: 111129
Citations: 19

Effect of Epigallocatechin-3-gallate on DMPC Oxidation Revealed by Infrared Spectroscopy

Authors: Pires, F., Rodrigues, B., Magalhães-Mota, G., Ribeiro, P.A., Raposo, M.
Conference: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture)
Year: 2020

 

 

 

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Published on by Invention Awards

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Beijing Institute of Technology, China.

Dr. Xiaogang Liu is a dedicated Lecturer at the Zhuhai Campus of Beijing Institute of Technology. With a strong foundation in Biochemistry and Molecular Biology, he specializes in Chemical Biology. His research primarily focuses on Computational Chemistry to study pH-Responsive Fluorescent Probes and develop related software. In addition to his research contributions, he is passionate about teaching and mentoring students in the areas of Molecular Biology and Immunology.

Profile

Orcid

Education 🎓

Xiaogang Liu earned his Bachelor’s Degree in Biochemistry from Shanxi University, where he laid the groundwork for his extensive studies in the fields of Biochemistry and Molecular Biology. During his time at Shanxi University, he gained a solid understanding of the core principles of biochemical processes and molecular interactions, which set the stage for his later academic pursuits. His education at Shanxi University sparked his passion for Chemical Biology, ultimately shaping his career in research and teaching.

Experience 💼

Dr. Liu has taken on multiple roles in research and academia. Currently, as a Lecturer at Beijing Institute of Technology, he actively teaches and supervises students while also conducting research in Bioinformatics and Chemical Biology. His work focuses on exploring computational methodologies to understand complex chemical systems and biological molecules.

Research Interests 🔬

Chemical Biology: Investigating pH-Responsive Fluorescent Probes

Computational Chemistry: Developing software to support chemical biology research

Bioinformatics: Exploring the intersection of biology and computing to enhance molecular biology applications
Dr. Liu's research also delves into the integration of Computational Chemistry and Chemical Biology to advance understanding in fields like fluorescence sensing, probe design, and software development.

Selected Publications 📚

Computational Chemistry Study of pH-Responsive Fluorescent Probes and Development of Supporting Software
Journal: Molecules (2025), Volume: 30(2), Article 273
Contributors: Xiaogang Liu

Large Scale Virtual Screening for Finding Inhibitor against the RNA-dependent RNA Polymerase from Herbal Medicine for SARS-Cov-2 Therapy
Proceedings of the 11th International Conference on Biomedical Engineering and Bioinformatics (2022)
Contributors: Xiaogang Liu, Zirong Liang, Shiye Wu, Ying Wang, Binquan Gou

Virtual Screening for Finding Inhibitor Against the Main Protease of SARS-Cov-2 from the FDA-Approved Drugs Database
International Conference on Biomedical and Intelligent Systems (IC-BIS 2022) (2022-12-06)
Contributors: Xiaogang Liu, Shiye Wu, Zitong Zhu, Ying Wang, Binquan Gou

Teaching Reform and Application of Cell Biology in Bioengineering Specialty
Science & Technology Information (2021-12-13)
Contributors: Xiaogang Liu

 

 

Prof. Junyu Zhou | Medical and Prevention | Young Scientist Award

Published on by Invention Awards

Prof. Junyu Zhou | Medical and Prevention | Young Scientist Award

Peking University, China.

Prof. Junyu Zhou is a pioneering researcher in nutritional genomics, metabolic disorders, and personalized medicine. He leverages bioinformatics, computational biology, and experimental approaches to explore gene-diet interactions, focusing on Asian populations. His innovative work includes developing AI models for bioactive compound prediction and uncovering gut microbiota's role in metabolic health. Junyu's recent research extends to natural compound discovery for neurodegenerative diseases, emphasizing computational screening with advanced AI techniques.

Profile

Scopus

Orcid

Education 🎓

Junyu Zhou holds advanced degrees in fields related to nutritional genomics and computational biology. His academic training provides a strong foundation for his cutting-edge research in metabolic disorders and personalized medicine.

Experience 💼

As an Assistant Researcher at Peking University, Junyu Zhou has led and collaborated on multiple groundbreaking projects. His experience spans computational modeling, experimental validations, and interdisciplinary collaborations with global research teams in metabolic diseases and nutritional genomics.

Research Interests 🔬

Nutritional Genomics 🧬

Junyu Zhou investigates gene-diet interactions to understand how genetic variations influence nutritional responses, particularly in Asian populations. His work aims to develop personalized dietary recommendations to improve health outcomes.

Metabolic Diseases 🩺

Focusing on conditions such as diabetes and obesity, Junyu studies the underlying mechanisms of metabolic disorders. His research integrates genetics and gut microbiota to unveil new therapeutic targets.

Computational Biology & Bioinformatics 💻

Junyu applies advanced computational tools to analyze genetic data and predict drug-target interactions. His expertise in bioinformatics helps bridge data science and biology for innovative discoveries.

Gut Microbiota 🌱

Exploring the role of gut microbiota in metabolic health, Junyu's research uncovers microbial contributions to diseases and identifies probiotic strategies for improved metabolic functions.

Natural Product Research 🌿

Junyu's work includes computational screening of natural compounds, focusing on their potential to treat diseases such as Alzheimer's and neurodegenerative disorders.

Personalized Medicine 🩹

By integrating genomics and computational biology, Junyu develops precision healthcare approaches, tailoring interventions to individual genetic and metabolic profiles.

Machine Learning in Drug Discovery 🤖

Junyu employs AI-driven techniques to streamline drug discovery processes. His work includes predictive models for bioactive compounds, enhancing efficiency in identifying new therapeutic agents.

Publications Top Notes 📚

Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype, Published in: International Journal of Molecular Sciences, 2024, Contributors: Yuan, H.; Wu, X.; Wang, X.; Zhou, J.-Y.; Park, S. Link

Predicting structure-targeted food bioactive compounds for middle-aged and elderly Asians with myocardial infarction: insights from genetic variations and bioinformatics-integrated deep learning analysis, Published in: Food & Function, 2024, Contributors: Junyu Zhou; Heng Yuan; Sunmin Park. Link

Association of Metabolic Diseases and Moderate Fat Intake with Myocardial Infarction Risk, Published in: Nutrients, December 11, 2024, Contributors: Junyu Zhou; Meiling Liu; Sunmin Park. Link

 

 

 

 

 

 

 

 

 

 

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Published on by Invention Awards

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link